Phase 2 Kaposiform Hemangioendothelioma Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Kaposiform Hemangioendothelioma (KHE)Kasabach Merritt Phenomenon
Yi Ji76 enrolled1 locationNCT07656909
Recruiting
Phase 2
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
West China Hospital50 enrolled1 locationNCT04056962